Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Tifab Deficiency Protects Against Stress-Induced Bone Marrow Failure at the Expense of Pre-Leukemic Selection

Madeline Niederkorn, BS, Melinda Varney, PhD, Ken Greis, PhD, Ruhikanta A. Meetei, PhD, Kwangmin Choi, PhD, Daniel Starczynowski, PhD

Blood (2017) 130 (Supplement 1): 2960.

https://doi.org/10.1182/blood.V130.Suppl_1.2960.2960

Published: 2017

Journal Articles

Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands

Tomoya Muto, MD PhD, Melinda Varney, PhD, Callum Walker, MSc, Lyndsey Bolanos, BSc, Kathleen Hueneman, BSc, Daniel Starczynowski, PhD

Blood (2017) 130 (Supplement 1): 1674.

https://doi.org/10.1182/blood.V130.Suppl_1.1674.1674

Published: 2017

Journal Articles

Tifab , a Del(5q) MDS/AML Gene, Regulates USP15 Activity and p53

Madeline Niederkorn, BS, Melinda Varney, PhDBS, Molly A Smith, BS, Ruhikanta A. Meetei, PhD, Daniel T Starczynowski, PhD

Blood (2016) 128 (22): 1130.

https://doi.org/10.1182/blood.V128.22.1130.1130

Published: 2016

Journal Articles

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Melinda Varney, PhD, Susanne Christie, Madeline Niederkorn, Jing Fang, MD, PhD, Andres Jerez, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Jun-ichiro Inoue, PhD, Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 102.

https://doi.org/10.1182/blood.V122.21.102.102

Published: 2013

Journal Articles

Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.

Melinda Varney, PhD, Andres Jerez, MD, PhD, Jing Fang, MD/PhD, David Miller, Lyndsey Bolanos, BSc, Aly Karsan, MD, Jaroslaw P. Maciejewski, MD, PhD, Daniel T Starczynowski, PhD

Blood (2012) 120 (21): 2812.

https://doi.org/10.1182/blood.V120.21.2812.2812

Published: 2012

Journal Articles

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, Christopher Rasch, Melinda Varney, Mark Wunderlich, Susumu Goyama, Gerrit Jansen, Jacqueline Cloos, Carmela Rigolino, Agostino Cortelezzi, James C. Mulloy, Esther N. Oliva, Maria Cuzzola, Daniel T. Starczynowski

Blood (2012) 120 (4): 858–867.

https://doi.org/10.1182/blood-2012-02-407999

Published: 2012

Includes: Supplemental data

NARROW

Tifab Deficiency Protects Against Stress-Induced Bone Marrow Failure at the Expense of Pre-Leukemic Selection

Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands

Tifab , a Del(5q) MDS/AML Gene, Regulates USP15 Activity and p53

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Email alerts

ASH Publications

American Society of Hematology

Tifab Deficiency Protects Against Stress-Induced Bone Marrow Failure at the Expense of Pre-Leukemic Selection

Innate Immune Signal Pathway Activation Induced By Combined Loss of Del(5q) MDS Genes, Tifab and Mir-146a, Accelerates Hematopoietic Stem Cell Exhaustion Driven By Chronic Exposure to a TLR Ligands

Tifab , a Del(5q) MDS/AML Gene, Regulates USP15 Activity and p53

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only